|
FR2686899B1
(fr)
*
|
1992-01-31 |
1995-09-01 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
|
|
US6841617B2
(en)
*
|
2000-09-28 |
2005-01-11 |
Battelle Memorial Institute |
Thermogelling biodegradable aqueous polymer solution
|
|
US6451346B1
(en)
*
|
1998-12-23 |
2002-09-17 |
Amgen Inc |
Biodegradable pH/thermosensitive hydrogels for sustained delivery of biologically active agents
|
|
EP1173151B1
(en)
*
|
1999-04-16 |
2003-07-09 |
Novo Nordisk A/S |
Dry, mouldable drug formulation
|
|
US20040009229A1
(en)
*
|
2000-01-05 |
2004-01-15 |
Unger Evan Charles |
Stabilized nanoparticle formulations of camptotheca derivatives
|
|
US6998137B2
(en)
*
|
2000-04-07 |
2006-02-14 |
Macromed, Inc. |
Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix
|
|
AU2001266557A1
(en)
*
|
2000-04-12 |
2001-10-23 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
AU2001264623A1
(en)
*
|
2000-05-16 |
2001-11-26 |
Biocure, Inc. |
Membranes formed from amphiphilic copolymers
|
|
US7767197B2
(en)
|
2000-06-22 |
2010-08-03 |
Endo Pharmaceuticals Colorado LLC |
Delivery vehicle composition and methods for delivering antigens and other drugs
|
|
EP1313425B1
(en)
*
|
2000-07-14 |
2007-03-07 |
Novo Nordisk A/S |
Method of moulding a pharmaceutical composition in a packaging material
|
|
CA2420401A1
(en)
*
|
2000-08-29 |
2002-03-07 |
Contivo, Inc. |
Virtual groups
|
|
US7666445B2
(en)
*
|
2000-10-20 |
2010-02-23 |
The Trustees Of The University Of Pennsylvania |
Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use
|
|
DK1343530T3
(da)
*
|
2000-11-09 |
2007-10-15 |
Astrazeneca Ab |
Oral farmaceutisk sammensætning, der indeholder en blokcopolymer
|
|
US20040185101A1
(en)
*
|
2001-03-27 |
2004-09-23 |
Macromed, Incorporated. |
Biodegradable triblock copolymers as solubilizing agents for drugs and method of use thereof
|
|
FR2822834B1
(fr)
*
|
2001-04-02 |
2005-02-25 |
Flamel Tech Sa |
Suspension colloidale de nanoparticules a base de copolymeres amphiphile pour la vectorisation de principes actifs et leur mode de preparation
|
|
AU2002310122A1
(en)
*
|
2001-05-25 |
2002-12-09 |
Human Genome Sciences, Inc. |
Chemokine beta-1 fusion proteins
|
|
KR100566911B1
(ko)
*
|
2001-06-25 |
2006-04-03 |
주식회사 삼양사 |
약물 전달체용 음이온기-함유 양친성 블록 공중합체 및 그의 양이온성 약물과의 복합체
|
|
AU2002319922B2
(en)
|
2001-07-14 |
2004-12-16 |
Samyang Biopharmaceuticals Corporation |
Positively charged amphiphilic block copolymer as drug carrier and complex thereof with negatively charged drug
|
|
US6592899B2
(en)
|
2001-10-03 |
2003-07-15 |
Macromed Incorporated |
PLA/PLGA oligomers combined with block copolymers for enhancing solubility of a drug in water
|
|
US7309498B2
(en)
*
|
2001-10-10 |
2007-12-18 |
Belenkaya Bronislava G |
Biodegradable absorbents and methods of preparation
|
|
US7282216B2
(en)
*
|
2001-11-12 |
2007-10-16 |
Alkermes Controlled Therapeutics, Inc. |
Biocompatible polymer blends and uses thereof
|
|
US8454997B2
(en)
|
2001-12-18 |
2013-06-04 |
Novo Nordisk A/S |
Solid dose micro implant
|
|
AU2002364587A1
(en)
*
|
2001-12-21 |
2003-07-30 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
JP5424521B2
(ja)
*
|
2001-12-21 |
2014-02-26 |
ヒューマン ジノーム サイエンシーズ， インコーポレイテッド |
アルブミン融合タンパク質
|
|
WO2003080629A2
(en)
*
|
2002-02-25 |
2003-10-02 |
Guilford Pharmaceuticals, Inc. |
Phosphorus-containing compounds with polymeric chains, and methods of making and using the same
|
|
ITMI20020865A1
(it)
*
|
2002-04-22 |
2003-10-22 |
Novamont Spa |
Poliesteri biodegradabili ottenuti mediante estrusione reattiva
|
|
US20030204180A1
(en)
*
|
2002-04-30 |
2003-10-30 |
Kimberly-Clark Worldwide, Inc. |
Temperature responsive delivery systems
|
|
FR2840614B1
(fr)
|
2002-06-07 |
2004-08-27 |
Flamel Tech Sa |
Polyaminoacides fonctionnalises par de l'alpha-tocopherol et leurs applications notamment therapeutiques
|
|
WO2003103608A2
(en)
*
|
2002-06-11 |
2003-12-18 |
The Burnham Institute |
Neuroprotective synergy of erythropoietin and insulin-like growth factor
|
|
US20030228366A1
(en)
*
|
2002-06-11 |
2003-12-11 |
Chung Shih |
Reconstitutable compositions of biodegradable block copolymers
|
|
US7649023B2
(en)
*
|
2002-06-11 |
2010-01-19 |
Novartis Ag |
Biodegradable block copolymeric compositions for drug delivery
|
|
US20030232088A1
(en)
*
|
2002-06-14 |
2003-12-18 |
Kimberly-Clark Worldwide, Inc. |
Materials with both bioadhesive and biodegradable components
|
|
US7037983B2
(en)
|
2002-06-14 |
2006-05-02 |
Kimberly-Clark Worldwide, Inc. |
Methods of making functional biodegradable polymers
|
|
US7160551B2
(en)
*
|
2002-07-09 |
2007-01-09 |
The Board Of Trustees Of The University Of Illinois |
Injectable system for controlled drug delivery
|
|
FR2843117B1
(fr)
*
|
2002-07-30 |
2004-10-15 |
Flamel Tech Sa |
Polyaminoacides fonctionnalises par au moins un groupement hydrophobe et leurs applications notamment therapeutiques
|
|
KR100684682B1
(ko)
*
|
2002-09-24 |
2007-02-22 |
아사히 가세이 케미칼즈 가부시키가이샤 |
글리콜산 공중합체 및 그의 제조 방법
|
|
MXPA05002561A
(es)
*
|
2002-10-25 |
2005-05-05 |
Pfizer Prod Inc |
Nuevas formulaciones de liberacion prolongada inyectables.
|
|
CN1738600A
(zh)
*
|
2002-11-12 |
2006-02-22 |
特瓦制药工业有限公司 |
用于口腔给药和舌下给药的替扎尼定药物组合物及剂型以及舌下或口腔给予替扎尼定的方法
|
|
US6992543B2
(en)
*
|
2002-11-22 |
2006-01-31 |
Raytheon Company |
Mems-tuned high power, high efficiency, wide bandwidth power amplifier
|
|
US7220431B2
(en)
|
2002-11-27 |
2007-05-22 |
Regents Of The University Of Minnesota |
Methods and compositions for applying pharmacologic agents to the ear
|
|
CA2513213C
(en)
|
2003-01-22 |
2013-07-30 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
FR2855521B1
(fr)
*
|
2003-05-28 |
2005-08-05 |
Flamel Tech Sa |
Polyaminoacides fonctionnalises par au moins un groupement h ydrophobe et leurs applications notamment therapeutiques.
|
|
US7714077B2
(en)
*
|
2003-07-07 |
2010-05-11 |
Nof Corporation |
Triblock copolymer, method for producing the same, and biocompatible material
|
|
FR2860516B1
(fr)
*
|
2003-10-03 |
2006-01-13 |
Flamel Tech Sa |
Homopolyaminoacides telecheliques fonctionnalises par des groupements hydrophobes et leurs applications notamment therapeutiques
|
|
FR2862535B1
(fr)
*
|
2003-11-21 |
2007-11-23 |
Flamel Tech Sa |
Formulations pharmaceutiques pour la liberation prolongee d'interleukines et leurs applications therapeutiques
|
|
FR2862536B1
(fr)
*
|
2003-11-21 |
2007-11-23 |
Flamel Tech Sa |
Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s), ainsi que leurs applications notamment therapeutiques
|
|
US8329203B2
(en)
*
|
2004-01-12 |
2012-12-11 |
The Trustees Of The University Of Pennsylvania |
Drug-containing implants and methods of use thereof
|
|
US8221778B2
(en)
*
|
2005-01-12 |
2012-07-17 |
The Trustees Of The University Of Pennsylvania |
Drug-containing implants and methods of use thereof
|
|
WO2005070332A1
(en)
*
|
2004-01-12 |
2005-08-04 |
The Trustees Of The University Of Pennsylvania |
Long-term delivery formulations and methods of use thereof
|
|
EP1703915A2
(en)
*
|
2004-01-13 |
2006-09-27 |
Vasogenix Pharmaceuticals, Inc. |
Methods of using cgrp for cardiovascular and renal indications
|
|
WO2005067890A2
(en)
*
|
2004-01-13 |
2005-07-28 |
Vasogenix Pharmaceuticals, Inc. |
Controlled release cgrp delivery composition for cardiovascular and renal indications
|
|
WO2005070445A2
(en)
*
|
2004-01-13 |
2005-08-04 |
Vasogenix Pharmaceuticals, Inc. |
Methods for treating acute myocardial infarction by calcitonin gene related peptide and compositions containing the same
|
|
WO2005074546A2
(en)
|
2004-02-02 |
2005-08-18 |
Ambrx, Inc. |
Modified human growth hormone polypeptides and their uses
|
|
US20060039985A1
(en)
*
|
2004-04-27 |
2006-02-23 |
Bennett David B |
Methotrexate compositions
|
|
NZ582684A
(en)
*
|
2004-06-18 |
2011-05-27 |
Ambrx Inc |
Use of an antibody or binding fragment thereof comprising a non naturally encoded amino acid coupled to a linker
|
|
JP2008507280A
(ja)
*
|
2004-07-21 |
2008-03-13 |
アンブレツクス・インコーポレイテツド |
非天然コードアミノ酸を用いた生合成ポリペプチド
|
|
US20060034889A1
(en)
|
2004-08-16 |
2006-02-16 |
Macromed, Inc. |
Biodegradable diblock copolymers having reverse thermal gelation properties and methods of use thereof
|
|
US20060275230A1
(en)
|
2004-12-10 |
2006-12-07 |
Frank Kochinke |
Compositions and methods for treating conditions of the nail unit
|
|
RU2007125978A
(ru)
|
2004-12-10 |
2009-01-20 |
Талима Терапьютикс, Инк. (Us) |
Композиции и способы для лечения заболеваний ногтей
|
|
WO2006073846A2
(en)
|
2004-12-22 |
2006-07-13 |
Ambrx, Inc. |
Methods for expression and purification of recombinant human growth hormone
|
|
KR20070090023A
(ko)
*
|
2004-12-22 |
2007-09-04 |
암브룩스, 인코포레이티드 |
변형 인간 성장 호르몬
|
|
MX2007007587A
(es)
|
2004-12-22 |
2007-12-11 |
Ambrx Inc |
Formulaciones de la hormona del crecimiento humano que comprenden un aminoacido codificado de manera no natural.
|
|
ATE541934T1
(de)
*
|
2004-12-22 |
2012-02-15 |
Ambrx Inc |
Zusammensetzungen von aminoacyl-trna-synthetase und verwendungen davon
|
|
US8007775B2
(en)
*
|
2004-12-30 |
2011-08-30 |
Advanced Cardiovascular Systems, Inc. |
Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same
|
|
EP1838305A1
(en)
*
|
2005-01-21 |
2007-10-03 |
Richard H. Matthews |
Radiosensitizer formulations comprising nitrohistidine derivatives
|
|
WO2006082221A1
(en)
*
|
2005-02-03 |
2006-08-10 |
Cinvention Ag |
Drug delivery materials made by sol/gel technology
|
|
US20060224095A1
(en)
*
|
2005-04-05 |
2006-10-05 |
University Of New Hampshire |
Biocompatible polymeric vesicles self assembled from triblock copolymers
|
|
KR20080026135A
(ko)
|
2005-06-03 |
2008-03-24 |
암브룩스, 인코포레이티드 |
개선된 인간 인터페론 분자 및 이의 용도
|
|
DE102005033101A1
(de)
*
|
2005-07-15 |
2007-01-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Resorbierbare Polyetherester und ihre Verwendung zur Herstellung von medizinischen Implantaten
|
|
AU2006278328A1
(en)
*
|
2005-08-04 |
2007-02-15 |
Angiotech International Ag |
Block copolymer compositions and uses thereof
|
|
WO2007021297A1
(en)
|
2005-08-18 |
2007-02-22 |
Ambrx, Inc. |
COMPOSITIONS OF tRNA AND USES THEREOF
|
|
CN1939534B
(zh)
*
|
2005-09-27 |
2010-12-01 |
长春金赛药业股份有限公司 |
含有人生长激素或人粒细胞巨噬细胞刺激因子的用于治疗损伤和溃疡的外用制剂
|
|
US7669732B2
(en)
*
|
2005-10-25 |
2010-03-02 |
Imi Cornelius Inc. |
Cup lid dispenser
|
|
US8124128B2
(en)
*
|
2005-11-08 |
2012-02-28 |
Industrial Technology Research Institute |
Amphiphilic block copolymers and nano particles comprising the same
|
|
HRP20110404T1
(hr)
*
|
2005-11-08 |
2011-08-31 |
Ambrx |
Ubrzivači za modifikaciju ne-prirodnih aminokiselina i polipeptida ne-prirodnih aminokiselina
|
|
EP1951890A4
(en)
*
|
2005-11-16 |
2009-06-24 |
Ambrx Inc |
PROCESSES AND COMPOSITIONS WITH NON-NATURAL AMINO ACIDS
|
|
FR2893943B1
(fr)
*
|
2005-11-28 |
2011-08-19 |
Centre Nat Rech Scient |
Procede de preparation de copolymeres par polymerisation anionique sans solvant
|
|
WO2007067624A2
(en)
|
2005-12-06 |
2007-06-14 |
Tyco Healthcare Group Lp |
Bioabsorbable compounds and compositions containing them
|
|
US20070142287A1
(en)
*
|
2005-12-20 |
2007-06-21 |
Biomed Solutions, Llc |
Compositions And Methods For Treatment Of Cancer
|
|
US20070154546A1
(en)
*
|
2005-12-30 |
2007-07-05 |
Zhang Jack Y |
Sustained release pharmaceutical compositions
|
|
KR100784485B1
(ko)
|
2006-01-18 |
2007-12-11 |
한국과학기술연구원 |
생분해성 온도 감응성 폴리포스파젠계 하이드로젤, 그의제조방법 및 그의 용도
|
|
ATE458773T1
(de)
*
|
2006-03-09 |
2010-03-15 |
Coloplast As |
Abbaubare copolymere mit einem hydrophilen block mit verbesserter biokompatibilität für die weichgeweberegeneration
|
|
US20070224234A1
(en)
*
|
2006-03-22 |
2007-09-27 |
Mark Steckel |
Medical devices having biodegradable polymeric regions
|
|
US7740877B2
(en)
|
2006-04-07 |
2010-06-22 |
University Of Utah Research Foundation |
Aliphatically modified biodegradable block copolymers as thermogelling polymers
|
|
CA2649915A1
(en)
*
|
2006-04-20 |
2007-11-01 |
University Of Utah Research Foundation |
Polymeric compositions and methods of making and using thereof
|
|
US8747870B2
(en)
|
2006-04-20 |
2014-06-10 |
University Of Utah Research Foundation |
Polymeric compositions and methods of making and using thereof
|
|
US20100119529A1
(en)
*
|
2006-05-12 |
2010-05-13 |
Furgeson Darin Y |
Elastin-like polymer delivery vehicles
|
|
US7794495B2
(en)
*
|
2006-07-17 |
2010-09-14 |
Advanced Cardiovascular Systems, Inc. |
Controlled degradation of stents
|
|
CN104193815A
(zh)
|
2006-09-08 |
2014-12-10 |
Ambrx公司 |
经修饰的人类血浆多肽或Fc骨架和其用途
|
|
PT2064333E
(pt)
|
2006-09-08 |
2014-06-09 |
Ambrx Inc |
Supressor híbrido arnt para células de vertebrados
|
|
ES2457527T3
(es)
*
|
2006-09-08 |
2014-04-28 |
Ambrx, Inc. |
ARNt Supresor hibrido en células de vertebrados
|
|
JP2008069324A
(ja)
*
|
2006-09-15 |
2008-03-27 |
Mitsui Chemicals Inc |
生分解性を有する水環境応答型ポリマーを含む水崩壊性組成物および水崩壊性成形体
|
|
CN1965802B
(zh)
*
|
2006-11-09 |
2010-04-14 |
复旦大学 |
一种聚乙二醇化药物的可注射性水凝胶制剂及其制备方法
|
|
US20080114076A1
(en)
*
|
2006-11-09 |
2008-05-15 |
Alcon Manufacturing Ltd. |
Punctal plug comprising a water-insoluble polymeric matrix
|
|
MX2009004856A
(es)
*
|
2006-11-09 |
2009-06-05 |
Alcon Res Ltd |
Matriz polimerica insoluble en agua para suministro de farmaco.
|
|
JP5297632B2
(ja)
*
|
2006-11-17 |
2013-09-25 |
独立行政法人国立循環器病研究センター |
血液凝固抑制材料並びにそれを用いたコーティング材料及び生体留置部材
|
|
US8969415B2
(en)
*
|
2006-12-01 |
2015-03-03 |
Allergan, Inc. |
Intraocular drug delivery systems
|
|
US20080140106A1
(en)
*
|
2006-12-12 |
2008-06-12 |
Kimberly-Clark Worldwide, Inc. |
Enhanced cuff sealing for endotracheal tubes
|
|
GB0701896D0
(en)
*
|
2007-02-01 |
2007-03-14 |
Regentec Ltd |
Composition
|
|
KR20140012199A
(ko)
|
2007-03-30 |
2014-01-29 |
암브룩스, 인코포레이티드 |
변형된 ｆｇｆ-21 폴리펩티드 및 그 용도
|
|
CN100445313C
(zh)
*
|
2007-04-24 |
2008-12-24 |
上海同杰良生物材料有限公司 |
一种聚乳酸/聚醚二元醇共聚物的制备方法
|
|
NZ580686A
(en)
|
2007-05-02 |
2012-11-30 |
Ambrx Inc |
Modified interferon beta polypeptides and their uses
|
|
FR2915683B1
(fr)
*
|
2007-05-03 |
2009-08-07 |
Flamel Technologies Sa |
Formulations pharmaceutiques auto-precipitantes pour la liberation modifiee de principe actif
|
|
WO2008134828A2
(en)
|
2007-05-04 |
2008-11-13 |
Katholieke Universiteit Leuven |
Tissue degeneration protection
|
|
KR100968591B1
(ko)
*
|
2007-06-14 |
2010-07-08 |
한국과학기술연구원 |
약물전달용 폴리포스파젠계 하이드로젤, 그의 제조방법 및그의 용도
|
|
KR20080110473A
(ko)
|
2007-06-14 |
2008-12-18 |
한국과학기술연구원 |
화학적 가교 결합을 가지는 포스파젠계 고분자 하이드로젤,그의 제조방법 및 그의 용도
|
|
US20090004243A1
(en)
|
2007-06-29 |
2009-01-01 |
Pacetti Stephen D |
Biodegradable triblock copolymers for implantable devices
|
|
JP5171146B2
(ja)
*
|
2007-07-27 |
2013-03-27 |
学校法人 関西大学 |
温度応答性を有する生分解性ポリマー及びその製造方法
|
|
EP2200613B1
(en)
|
2007-09-21 |
2018-09-05 |
The Johns Hopkins University |
Phenazine derivatives and uses thereof
|
|
US8642062B2
(en)
|
2007-10-31 |
2014-02-04 |
Abbott Cardiovascular Systems Inc. |
Implantable device having a slow dissolving polymer
|
|
EP2930182A1
(en)
|
2007-11-20 |
2015-10-14 |
Ambrx, Inc. |
Modified insulin polypeptides and their uses
|
|
US8853351B2
(en)
*
|
2007-12-31 |
2014-10-07 |
Samyang Biopharmaceuticals Corporation |
Highly pure amphiphilic copolymer comprising hydrophobic block from alpha-hydroxy acid and process for the preparation thereof
|
|
US20090183503A1
(en)
*
|
2008-01-18 |
2009-07-23 |
Alberto Verdesi |
Exhaust apparatus
|
|
EP3103880A1
(en)
|
2008-02-08 |
2016-12-14 |
Ambrx, Inc. |
Modified leptin polypeptides and their uses
|
|
WO2009100422A2
(en)
*
|
2008-02-08 |
2009-08-13 |
Zimmer, Inc. |
Drug delivery system comprising microparticles and gelation system
|
|
UA90013C2
(ru)
|
2008-03-19 |
2010-03-25 |
Давид Анатолійович Нога |
Фармацевтическая композиция, содержащая инсулин, и способ его получения
|
|
TWI388591B
(zh)
*
|
2008-03-28 |
2013-03-11 |
Ind Tech Res Inst |
溫度敏感性材料
|
|
US8916188B2
(en)
*
|
2008-04-18 |
2014-12-23 |
Abbott Cardiovascular Systems Inc. |
Block copolymer comprising at least one polyester block and a poly (ethylene glycol) block
|
|
US20090285873A1
(en)
*
|
2008-04-18 |
2009-11-19 |
Abbott Cardiovascular Systems Inc. |
Implantable medical devices and coatings therefor comprising block copolymers of poly(ethylene glycol) and a poly(lactide-glycolide)
|
|
US20090297584A1
(en)
*
|
2008-04-18 |
2009-12-03 |
Florencia Lim |
Biosoluble coating with linear over time mass loss
|
|
US11969501B2
(en)
|
2008-04-21 |
2024-04-30 |
Dompé Farmaceutici S.P.A. |
Auris formulations for treating otic diseases and conditions
|
|
EP2278999B1
(en)
|
2008-04-21 |
2025-01-29 |
Dompé farmaceutici S.p.A. |
Auris formulations for treating otic diseases and conditions
|
|
BRPI0912482A2
(pt)
|
2008-05-14 |
2020-08-18 |
Otonomy, Inc |
composições de corticosteróide de liberação controlada e métodos para o tratamento de distúrbios auriculares
|
|
US8652506B2
(en)
*
|
2008-06-05 |
2014-02-18 |
Boston Scientific Scimed, Inc. |
Bio-degradable block co-polymers for controlled release
|
|
WO2010005726A2
(en)
|
2008-06-16 |
2010-01-14 |
Bind Biosciences Inc. |
Therapeutic polymeric nanoparticles with mtor inhibitors and methods of making and using same
|
|
JP2012501966A
(ja)
|
2008-06-16 |
2012-01-26 |
バインド バイオサイエンシズ インコーポレイテッド |
ビンカアルカロイド含有治療用ポリマーナノ粒子並びにその製造方法及び使用方法
|
|
EA020954B1
(ru)
|
2008-06-16 |
2015-03-31 |
Бинд Терапьютикс, Инк. |
Загруженные лекарственным средством полимерные наночастицы, фармацевтическая композиция и способ лечения рака
|
|
JP5421366B2
(ja)
|
2008-07-21 |
2014-02-19 |
オトノミ―，インク． |
制御放出性の耳の構造体調節および生来の免疫システム調節化合物および耳の障害の処置のための方法
|
|
US8318817B2
(en)
|
2008-07-21 |
2012-11-27 |
Otonomy, Inc. |
Controlled release antimicrobial compositions and methods for the treatment of otic disorders
|
|
US8784870B2
(en)
*
|
2008-07-21 |
2014-07-22 |
Otonomy, Inc. |
Controlled release compositions for modulating free-radical induced damage and methods of use thereof
|
|
AU2009274076C1
(en)
|
2008-07-23 |
2014-04-17 |
Ambrx, Inc. |
Modified bovine G-CSF polypeptides and their uses
|
|
JP5435534B2
(ja)
*
|
2008-08-27 |
2014-03-05 |
多木化学株式会社 |
生体材料
|
|
US9121024B2
(en)
|
2008-09-26 |
2015-09-01 |
Ambrx, Inc. |
Non-natural amino acid replication-dependent microorganisms and vaccines
|
|
PL2342223T3
(pl)
|
2008-09-26 |
2017-09-29 |
Ambrx, Inc. |
Zmodyfikowane polipeptydy zwierzęcej erytropoetyny i ich zastosowania
|
|
US20100081622A1
(en)
*
|
2008-09-29 |
2010-04-01 |
Sanos Bioscience A/S |
Reduction of parathyroid hormone levels
|
|
US8993068B2
(en)
|
2008-11-04 |
2015-03-31 |
The Trustees Of Columbia University In The City Of New York |
Heterobifunctional polymers and methods for layer-by-layer construction of multilayer films
|
|
US8563041B2
(en)
*
|
2008-12-12 |
2013-10-22 |
Bind Therapeutics, Inc. |
Therapeutic particles suitable for parenteral administration and methods of making and using same
|
|
ES2776126T3
(es)
|
2008-12-15 |
2020-07-29 |
Pfizer |
Nanopartículas de circulación prolongada para la liberación sostenida de agentes terapéuticos
|
|
TWI374903B
(en)
*
|
2008-12-31 |
2012-10-21 |
Ind Tech Res Inst |
Biodegradable copolymer hydrogel materials
|
|
US9200112B2
(en)
*
|
2009-08-10 |
2015-12-01 |
Ethicon, Inc. |
Semi-crystalline, fast absorbing polymer formulation
|
|
US8753621B2
(en)
*
|
2009-09-18 |
2014-06-17 |
Protherics Salt Lake City, Inc. |
BAB triblock polymers having improved release characteristics
|
|
MX343980B
(es)
*
|
2009-09-18 |
2016-12-01 |
Protherics Medicines Dev Ltd * |
Copolimeros en tribloque bab que tienen características de liberación mejorada.
|
|
US9155722B2
(en)
*
|
2009-09-18 |
2015-10-13 |
Protherics Salt Lake City, Inc. |
Reconstitutable reverse thermal gelling polymers
|
|
BR112012005864A2
(pt)
*
|
2009-09-18 |
2016-11-22 |
Protherics Medicines Dev Ltd |
polímeros de gelação térmicos inversos reconstituíveis
|
|
EP2490722A4
(en)
|
2009-10-21 |
2014-03-05 |
Otonomy Inc |
MODULATION OF THE TEMPERATURE OF GELIFICATION OF FORMULATIONS CONTAINING POLOXAMERS
|
|
US9044524B2
(en)
|
2009-10-30 |
2015-06-02 |
Ethicon, Inc. |
Absorbable polyethylene diglycolate copolymers to reduce microbial adhesion to medical devices and implants
|
|
CN102811743B
(zh)
|
2009-12-11 |
2015-11-25 |
佰恩德治疗股份有限公司 |
冻干治疗颗粒的稳定制剂
|
|
EA201290499A1
(ru)
|
2009-12-15 |
2013-01-30 |
Байнд Байосайенсиз, Инк. |
Композиции терапевтических полимерных наночастиц с высокой температурой стеклования и высокомолекулярными сополимерами
|
|
BR112012015461A2
(pt)
|
2009-12-21 |
2017-01-10 |
Ambrx Inc |
polipeptídeos de somatotropina boviina modificados e seus usos
|
|
WO2011087810A1
(en)
|
2009-12-21 |
2011-07-21 |
Ambrx, Inc. |
Modified porcine somatotropin polypeptides and their uses
|
|
AU2011204275B2
(en)
|
2010-01-07 |
2015-04-02 |
Novartis Ag |
Methods and compositions for applying moxifloxacin to the ear
|
|
EP2343046A1
(en)
|
2010-01-08 |
2011-07-13 |
Nirvana's Tree House B.V. |
Functionalised triblock copolymers and compositions containing such polymers
|
|
US8551531B2
(en)
|
2010-04-12 |
2013-10-08 |
The Curators Of The University Of Missouri |
Pentablock polymers
|
|
EP2380920A1
(en)
*
|
2010-04-22 |
2011-10-26 |
QGel SA |
Hydrogel precursor formulation and production process thereof
|
|
US9567386B2
(en)
|
2010-08-17 |
2017-02-14 |
Ambrx, Inc. |
Therapeutic uses of modified relaxin polypeptides
|
|
ES2742296T3
(es)
|
2010-08-17 |
2020-02-13 |
Ambrx Inc |
Polipéptidos de relaxina modificados y sus usos
|
|
TWI480288B
(zh)
|
2010-09-23 |
2015-04-11 |
Lilly Co Eli |
牛顆粒細胞群落刺激因子及其變體之調配物
|
|
JP2013543844A
(ja)
*
|
2010-10-22 |
2013-12-09 |
バインド セラピューティックス インコーポレイテッド |
高分子コポリマーを含む治療用ナノ粒子
|
|
US20120164100A1
(en)
*
|
2010-11-02 |
2012-06-28 |
Ren-Ke Li |
Temperature sensitive hydrogel and block copolymers
|
|
US20140066439A1
(en)
|
2010-11-10 |
2014-03-06 |
Katholieke Universiteit Leuen, K.U.Leuven R&D |
Osteoclast activity
|
|
CN103380237A
(zh)
*
|
2010-12-15 |
2013-10-30 |
3M创新有限公司 |
可降解的纤维
|
|
US9006345B2
(en)
|
2011-03-25 |
2015-04-14 |
The Trustees Of Columbia University In The City Of New York |
Heterotrifunctional molecules and methods for the synthesis of dendrimeric materials
|
|
EP2691078A1
(en)
|
2011-03-31 |
2014-02-05 |
Ingell Technologies Holding B.V. |
Biodegradable compositions suitable for controlled release
|
|
GB201105455D0
(en)
*
|
2011-03-31 |
2011-05-18 |
British American Tobacco Co |
Blends of a polylactic acid and a water soluble polymer
|
|
DK2691079T3
(da)
|
2011-03-31 |
2020-09-28 |
Ingell Tech Holding B V |
Bionedbrydelige sammensætninger, der er egnet til kontrolleret udløsning
|
|
US8586020B2
(en)
|
2011-06-30 |
2013-11-19 |
Korea Institute Of Science And Technology |
Poly(organophosphazene) composition for biomaterials
|
|
WO2013055331A1
(en)
*
|
2011-10-12 |
2013-04-18 |
The Curators Of The University Of Missouri |
Pentablock polymers
|
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
|
BR112014012444B1
(pt)
|
2011-11-23 |
2021-12-14 |
Therapeuticsmd, Inc |
Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher
|
|
WO2013090652A1
(en)
*
|
2011-12-16 |
2013-06-20 |
Natureworks Llc |
Polylactide fibers
|
|
US9422387B2
(en)
*
|
2012-03-30 |
2016-08-23 |
Kimberly-Clark Worldwide, Inc. |
Dual responsive block copolymer compositions
|
|
CN102786675B
(zh)
*
|
2012-05-23 |
2014-04-30 |
上海交通大学 |
一种嵌段高分子及其合成方法和纳米颗粒的制备方法
|
|
CN103656679B
(zh)
*
|
2012-05-23 |
2016-02-10 |
上海交通大学 |
一种纳米颗粒的制备方法
|
|
DK2859017T3
(da)
|
2012-06-08 |
2019-05-13 |
Sutro Biopharma Inc |
Antistoffer omfattrende stedsspecifikke ikke-naturlige aminosyrerester, fremgangsmåder til fremstilling heraf og fremgangsmåder til anvendelse heraf
|
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
|
ES2611788T3
(es)
|
2012-06-26 |
2017-05-10 |
Sutro Biopharma, Inc. |
Proteínas de Fc modificadas que comprenden residuos de aminoácidos no naturales específicos del sitio, conjugados de las mismas, métodos para su preparación y métodos para su uso
|
|
EP3584255B1
(en)
|
2012-08-31 |
2022-02-16 |
Sutro Biopharma, Inc. |
Modified amino acids comprising an azido group
|
|
EP2895156B1
(en)
|
2012-09-17 |
2019-05-08 |
Pfizer Inc. |
Process for preparing therapeutic nanoparticles
|
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
BR112015022025A8
(pt)
|
2013-03-14 |
2019-12-10 |
Hallux Inc |
composição e uso de um agente ativo
|
|
WO2014186669A1
(en)
|
2013-05-16 |
2014-11-20 |
The Curators Of The University Of Missouri |
Drug loading pentablock polymers
|
|
ES2865473T3
(es)
|
2013-07-10 |
2021-10-15 |
Sutro Biopharma Inc |
Anticuerpos que comprenden múltiples residuos de aminoácidos no naturales sitio-específicos, métodos para su preparación y métodos de uso
|
|
US10682415B2
(en)
*
|
2013-07-22 |
2020-06-16 |
Wisconsin Alumni Research Foundation |
Thermogel formulation for combination drug delivery
|
|
US9486405B2
(en)
|
2013-08-27 |
2016-11-08 |
Otonomy, Inc. |
Methods for the treatment of pediatric otic disorders
|
|
WO2015054658A1
(en)
|
2013-10-11 |
2015-04-16 |
Sutro Biopharma, Inc. |
Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use
|
|
US10364141B2
(en)
*
|
2013-12-23 |
2019-07-30 |
Washington State University |
Block copolymer nanostructures formed by disturbed self-assembly and uses thereof
|
|
CN103819905B
(zh)
*
|
2014-03-07 |
2016-01-20 |
山东理工大学 |
一种用聚三亚甲基碳酸酯与聚乙烯吡咯烷酮对聚肽膜亲水性进行改进的方法
|
|
ES2834927T3
(es)
|
2014-03-14 |
2021-06-21 |
Pfizer |
Nanopartículas terapéuticas que comprenden un agente terapéutico y procedimientos de fabricación y uso de las mismas
|
|
RU2016143081A
(ru)
|
2014-05-22 |
2018-06-26 |
Терапьютиксмд, Инк. |
Натуральные комбинированные гормонозаместительные составы и терапии
|
|
AU2015284048A1
(en)
|
2014-07-03 |
2017-02-16 |
Otonomy, Inc. |
Sterilization of ciprofloxacin composition
|
|
KR101570849B1
(ko)
|
2014-08-18 |
2015-11-20 |
성균관대학교산학협력단 |
온도감응형 이온성 복합체, 이의 제조 방법, 및 이를 포함하는 생분해성 조성물
|
|
CN107108710B
(zh)
|
2014-10-24 |
2022-02-15 |
百时美施贵宝公司 |
修饰的fgf-21多肽及其用途
|
|
KR20170094794A
(ko)
|
2014-12-15 |
2017-08-21 |
더 존스 홉킨스 유니버시티 |
수니티닙 제제 및 눈 장애의 치료에서의 그의 사용 방법
|
|
US9925233B2
(en)
|
2015-01-30 |
2018-03-27 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
|
US9937223B2
(en)
|
2015-01-30 |
2018-04-10 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
|
US9687526B2
(en)
|
2015-01-30 |
2017-06-27 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
|
CN104645356B
(zh)
*
|
2015-01-30 |
2018-11-13 |
复旦大学 |
一类x射线显影的热致水凝胶及其制备方法
|
|
US9375478B1
(en)
|
2015-01-30 |
2016-06-28 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
|
US9744209B2
(en)
|
2015-01-30 |
2017-08-29 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
|
US9750785B2
(en)
|
2015-01-30 |
2017-09-05 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
|
EP3328898B8
(en)
|
2015-07-28 |
2024-04-10 |
6452728 Canada Corp. |
Trkb or trkc agonist compositions and methods for the treatment of otic conditions
|
|
US10786515B2
(en)
|
2015-08-03 |
2020-09-29 |
Tolmar International Limited |
Liquid polymer delivery system for extended administration of drugs
|
|
CN105062021B
(zh)
*
|
2015-08-18 |
2017-03-01 |
九江学院 |
一种非温敏可降解聚合物胶乳及其制备方法
|
|
US10441548B2
(en)
|
2015-11-12 |
2019-10-15 |
Graybug Vision, Inc. |
Aggregating microparticles for medical therapy
|
|
US11246863B2
(en)
|
2015-12-11 |
2022-02-15 |
Alk-Abelló, Inc. |
Ciprofloxacin otic composition and kits and method for using same
|
|
KR20180126582A
(ko)
|
2016-04-01 |
2018-11-27 |
쎄러퓨틱스엠디, 인코퍼레이티드 |
스테로이드 호르몬 약제학적 조성물
|
|
WO2017173044A1
(en)
|
2016-04-01 |
2017-10-05 |
Therapeuticsmd Inc. |
Steroid hormone compositions in medium chain oils
|
|
US11040004B2
(en)
|
2016-09-16 |
2021-06-22 |
Otonomy, Inc. |
Otic gel formulations for treating otitis externa
|
|
US9987369B2
(en)
|
2016-11-01 |
2018-06-05 |
International Business Machines Corporation |
Vitamin functionalized gel-forming block copolymers for biomedical applications
|
|
KR102670432B1
(ko)
|
2017-02-08 |
2024-05-28 |
브리스톨-마이어스 스큅 컴퍼니 |
약동학적 인핸서를 포함하는 변형된 렐락신 폴리펩티드 및 그의 용도
|
|
EP3600324A4
(en)
|
2017-03-23 |
2020-12-09 |
Graybug Vision, Inc. |
COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF EYE DISORDERS
|
|
US11911532B2
(en)
|
2017-03-29 |
2024-02-27 |
The Regents Of The University Of Colorado, A Body Corporate |
Reverse thermal gels and their use as vascular embolic repair agents
|
|
EP3600437A4
(en)
*
|
2017-03-31 |
2021-01-06 |
Rowan University |
OPTICALLY CLEAR IN-SITU EDUCATION OF BIODEGRADABLE NANOCARRIERS FOR EYE THERAPY AND THE SAME USING METHOD
|
|
JP2020519585A
(ja)
|
2017-05-10 |
2020-07-02 |
グレイバグ ビジョン インコーポレイテッド |
医学療法のための延長放出マイクロ粒子及びその懸濁液
|
|
LT3737233T
(lt)
|
2018-01-09 |
2025-11-25 |
|
Augimo faktoriaus preparatai ausims
|
|
WO2019154895A1
(en)
|
2018-02-08 |
2019-08-15 |
Strekin Ag |
Gel formulation for preventing or treating hearing loss
|
|
CN108250415B
(zh)
*
|
2018-02-09 |
2020-09-04 |
青岛科技大学 |
一种聚(γ-丁内酯)-b-聚乳酸嵌段共聚物及其制备方法
|
|
JP7441826B2
(ja)
|
2018-09-11 |
2024-03-01 |
アンブルックス，インコーポレイテッド |
インターロイキン－２ポリペプチド抱合物およびその使用
|
|
WO2020082057A1
(en)
|
2018-10-19 |
2020-04-23 |
Ambrx, Inc. |
Interleukin-10 polypeptide conjugates, dimers thereof, and their uses
|
|
EP3679928A1
(fr)
*
|
2019-01-08 |
2020-07-15 |
Atlangram |
Composition pharmaceutique de type gel pour traiter/prevenir une infection
|
|
CN119455003A
(zh)
|
2019-02-12 |
2025-02-18 |
Ambrx公司 |
包含抗体-tlr激动剂缀合物的组合物、方法和用途
|
|
EP3953400A4
(en)
*
|
2019-04-12 |
2023-01-04 |
The Regents of The University of Michigan |
T-BLOCK COPOLYMERS AND NANO-FIBROUS GEL-LIFTING MICROSPHERES COMPRISING THEM
|
|
WO2020254249A1
(en)
|
2019-06-21 |
2020-12-24 |
Proqr Therapeutics Ii B.V. |
Delivery of nucleic acids for the treatment of auditory disorders
|
|
WO2021064550A1
(en)
|
2019-09-30 |
2021-04-08 |
Tolmar International Limited |
Liquid polymer compositions and systems for extended delivery of peptides as active pharmaceutical ingredients
|
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|
|
CN115243726B
(zh)
|
2020-03-11 |
2025-07-15 |
北京泰德制药股份有限公司 |
白介素-2多肽偶联物及其使用方法
|
|
AU2021327396A1
(en)
|
2020-08-20 |
2023-03-23 |
Ambrx, Inc. |
Antibody-TLR agonist conjugates, methods and uses thereof
|
|
MX2023011480A
(es)
|
2021-04-03 |
2023-12-06 |
Ambrx Inc |
Conjugados anticuerpo anti-her2-fármaco y usos de estos.
|
|
CN113354823B
(zh)
*
|
2021-06-18 |
2023-03-31 |
四川大学 |
一种用于全降解血管支架的嵌段聚合物及制备方法
|
|
CN115814146B
(zh)
*
|
2022-11-01 |
2023-12-22 |
山东大学 |
一种仿生凝血机制的止血粉制备方法
|
|
WO2024137849A1
(en)
*
|
2022-12-20 |
2024-06-27 |
Northeast Ohio Medical University |
Gallium-loaded hydrogels for bone treatment
|
|
CN117720734B
(zh)
*
|
2023-12-22 |
2025-08-22 |
浙江中医药大学 |
聚乙二醇单甲醚-衣康酸基聚酯-聚乙二醇单甲醚两亲性嵌段共聚物及其制备方法和应用
|